These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29636196)

  • 41. Vascular Stains: Proposal for a Clinical Classification to Improve Diagnosis and Management.
    Rozas-Muñoz E; Frieden IJ; Roé E; Puig L; Baselga E
    Pediatr Dermatol; 2016 Nov; 33(6):570-584. PubMed ID: 27456075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Latest developments in capillary malformations].
    Dompmartin A
    Ann Dermatol Venereol; 2018; 145(8-9):475-476. PubMed ID: 30056991
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of varying pulse duration, wavelength, spot size, and fluence on the response of previously treated capillary vascular malformations to pulsed-dye laser treatment.
    Sivarajan V; Maclaren WM; Mackay IR
    Ann Plast Surg; 2006 Jul; 57(1):25-32. PubMed ID: 16799304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Vascular anomalies: information documents].
    Philandrianos C; Degardin N; Casanova D; Bardot J; Petit P; Bartoli JM; Magalon G
    Ann Chir Plast Esthet; 2011 Jun; 56(3):254-64. PubMed ID: 20598795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of port-wine stains (capillary malformation) with the flashlamp-pumped pulsed dye laser.
    Goldman MP; Fitzpatrick RE; Ruiz-Esparza J
    J Pediatr; 1993 Jan; 122(1):71-7. PubMed ID: 8419617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and Safety of the 532-nm KTP and Long-Pulsed 1064-nm Neodymium-doped Yttrium Aluminum Garnet Laser for Treatment of Vascular Malformations.
    Eichenfield DZ; Ortiz AE
    Dermatol Surg; 2020 Dec; 46(12):1535-1539. PubMed ID: 32371774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of facial hypertrophic capillary malformations with tumescent-assisted sclerotherapy.
    Kang M; Parsi K
    Australas J Dermatol; 2022 May; 63(2):235-239. PubMed ID: 35411941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Therapeutic indications for percutaneous laser in patients with vascular malformations and tumors].
    Labau D; Cadic P; Ouroussoff G; Ligeron C; Laroche JP; Guillot B; Dereure O; Quéré I; Galanaud JP
    J Mal Vasc; 2014 Dec; 39(6):363-72. PubMed ID: 25086985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple capillary malformations of progressive onset: Capillary malformation-arteriovenous malformation syndrome (CM-AVM).
    Gourier G; Audebert-Bellanger S; Vourc'h P; Fraitag S; L'Hérondelle K; Labouche A; Misery L; Abasq-Thomas C
    Ann Dermatol Venereol; 2018; 145(8-9):486-491. PubMed ID: 30056992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of phacomatosis pigmentovascularis: a combined multiple laser approach.
    Kono T; Erçöçen AR; Chan HH; Kikuchi Y; Hori K; Uezono S; Nozaki M
    Dermatol Surg; 2003 Jun; 29(6):642-6. PubMed ID: 12786710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lasers or light sources for treating port-wine stains.
    Faurschou A; Olesen AB; Leonardi-Bee J; Haedersdal M
    Cochrane Database Syst Rev; 2011 Nov; (11):CD007152. PubMed ID: 22071834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phenotypic association of presence of a somatic GNAQ mutation with port-wine stain distribution in capillary malformation.
    Lee KT; Park JE; Eom Y; Lim HS; Ki CS; Lim SY
    Head Neck; 2019 Dec; 41(12):4143-4150. PubMed ID: 31532024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Own clinical experience in treatment of port-wine stain with KTP 532 nm laser].
    Latkowski IT; Wysocki MS; Siewiera IP
    Wiad Lek; 2005; 58(7-8):391-6. PubMed ID: 16425790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PHACE syndrome misdiagnosed as a port-wine stain.
    Thomson J; Greig A; Lloyd C; Morrison D; Flohr C
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26177999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Typical Vascular and Pigmentary Dermoscopic Pattern of Capillary Malformations in Capillary Malformation-Arteriovenous Malformation Syndrome: Report of Four Cases.
    Gandon C; Bonniaud B; Collet E; Dalac S; Jeudy G; Vabres P
    Pediatr Dermatol; 2016 Sep; 33(5):e337-41. PubMed ID: 27480194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Commentary on Electrosclerotherapy as a Novel Treatment Option for Hypertrophic Capillary Malformations.
    Muir T
    Dermatol Surg; 2020 Apr; 46(4):499-500. PubMed ID: 31574036
    [No Abstract]   [Full Text] [Related]  

  • 57. Subepidermal Basal Cell carcinoma Following Laser Treatment of Congenital Capillary Malformation: A Case Report.
    Bulić K; Ilić I; Brenner E; Bulić L; Lorencin Bulić M
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):220-222. PubMed ID: 38651849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A cross-sectional survey of long-term outcomes for patients with diffuse capillary malformation with overgrowth.
    Liu KX; Prajapati VH; Liang MG; Mulliken JB; Lee MS
    J Am Acad Dermatol; 2018 May; 78(5):1023-1025. PubMed ID: 29203436
    [No Abstract]   [Full Text] [Related]  

  • 59. A direct comparison of pulsed dye, alexandrite, KTP and Nd:YAG lasers and IPL in patients with previously treated capillary malformations.
    McGill DJ; MacLaren W; Mackay IR
    Lasers Surg Med; 2008 Aug; 40(6):390-8. PubMed ID: 18649379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Capillary Malformation-Arteriovenous Malformation Syndrome.
    Sibley CD; Ramien ML
    JAMA Dermatol; 2019 Jun; 155(6):733. PubMed ID: 31017636
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.